Leptin and its OBRb receptor have been found to be overexpressed in breast tumors (Garofalo et al., 2006) and high serum or intratumoral levels of leptin have been associated with a poor prognosis in breast cancer (Wu et al., 2009), indicating an important role for this adipokine in breast tumor progression. Here, LEP is linked to breast neoplasm.